Silexion Therapeutics LTD

NASDAQ: SLXNW · Real-Time Price · USD
0.07
0.00 (1.01%)
At close: Jun 09, 2025, 9:30 AM

Silexion Therapeutics LTD Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q1 2023 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Mar 31, 2023 Mar 31, 2021
Net Income
-16.83M -16.52M -16.45M -5.4M -3.6M -2.18M -495.81K 313.19K -97.75K
Depreciation & Amortization
21K 25K 43K 31K 24K 16K 10K n/a n/a
Stock-Based Compensation
5.85M 5.86M 5.9M 130K 98K 66K 32K n/a n/a
Other Working Capital
666K 280K -648K 119K 79.52K 465.52K 43.52K 223.52K -713.21K
Other Non-Cash Items
3.68M 3.82M 3.99M 279K 191.12K 55.12K 102.12K -4.88K 5.78K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.07M -1.58M -203K 202K 123.52K 628.52K 198.52K 223.52K -713.21K
Operating Cash Flow
-9.1M -8.4M -6.73M -4.76M -3.16M -1.41M -153.17K 531.83K -805.18K
Capital Expenditures
-22K -22K -26K -16K -16K -10K -6K n/a 3.00
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 78K 78K 78K 78K n/a n/a
Investing Cash Flow
-22K -22K -26K 62K 62K 68K 72K n/a n/a
Debt Repayment
n/a n/a n/a n/a 385K 385K 385K 385K -149.99K
Common Stock Repurchased
n/a n/a n/a n/a -90.75M -90.75M -90.75M -90.75M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
12.54M 5.1M 2.3M n/a n/a n/a n/a n/a -2.55M
Financial Cash Flow
12.54M 5.1M 2.92M n/a -90.37M -90.37M -90.37M -90.37M 116.1M
Net Cash Flow
3.4M -3.38M -3.79M -4.74M -3.66M -1.85M -679K n/a n/a
Free Cash Flow
-9.12M -8.42M -6.75M -4.78M -3.18M -1.42M -159.17K 531.83K -805.18K